StockWatch
·
Pharmaceuticals
Business Update4 Aug 2026, 05:41 pm

Fermenta Biotech Lists on NSE, Expands Market Access

AI Summary

Fermenta Biotech Limited announced the successful listing of its 2,94,30,987 equity shares on the National Stock Exchange of India Limited (NSE) effective August 4, 2026. The shares will trade under the symbol FERMENTA and ISIN INE225B01021. This dual listing on both NSE and BSE (where it has been listed since 1977 under Scrip Code 506414) aims to increase accessibility for a wider investor community, enhance visibility, and facilitate more efficient price discovery. The company, a leading manufacturer of Vitamin D3 API and other nutritional ingredients, views this as a significant milestone in its 75-year journey, reflecting its growth and expanding global customer base.

Key Highlights

  • Fermenta Biotech's shares are now listed on the NSE, effective August 4, 2026.
  • Dual listing on NSE and BSE aims to increase investor accessibility and market visibility.
  • The move supports broader participation and more efficient price discovery.
  • This milestone aligns with the company's 75th anniversary and global expansion.